| Wilkes University |
Private |
Traditional |
PA |
This was an educational didactic lecture and student engagement activity in PHA 310, Clinical Research and Design, a First Professional Year Doctor of Pharmacy course. The objectives for the lecture and activity were:1. Summarize the history of diversity in clinical trial recruitment. 2. Describe the importance of diversity in clinical trials. 3. Understand the barriers to inclusion of marginalized groups into clinical trials4. Develop ways to improve the inclusion of marginalized groups in clinical trials. |
troy.lewis@wilkes.edu |
Education |
1/25/2024 |
|
1/25/2024 |
Inclusive Study Design, Language, Mistrust, Access (physical/geographical), Access (time), Knowledge, Student Pharmacists, Completed |
| University of California, San Diego |
Public |
Traditional |
CA |
Utilizing a Mobile Health Bus to enroll participants in underserved neighborhoods into clinical trials of vaccines. |
brookie@ucsd.edu |
Research, Service |
9/1/2020 |
Number of participants enrolled |
6/30/2022 |
Internal Institutional Partners, External Partners, Infectious Disease, Inclusive Study Design, Appropriate Language and Translation Services, Community-based Research, Language, Mistrust, Access (physical/geographical), Access (time), Internal Funding, For-profit Funding, Government Funding, Black or African American, Native Hawaiian or Other Pacific Islander, Hispanic or Latino, Patients, Community Members, Young Adults, Middle-Aged Adults, Older Adults, Medicare Population, Medicaid Population, Individuals Below Federal Poverty Level, Health Professional Shortage Area, Urban, Other health professionals, Completed |
| Texas A&M University |
Public |
Traditional |
TX |
Racial and Ethnic Minority Group (REMG) participation in clinical trials, including those focused on precision therapy optimization, has been historically low. In 2020, the Center for Drug Evaluation and Research (CDER) approved 53 novel drugs representing 32,000 participants in trials as follows: 75% White, 8% Black or African American, 6% Asian, and 11% Hispanic/Latino.3 Representation of American Indian or Alaska Natives or Alaska Natives and Native Hawaiians or Other Pacific Islanders in clinical trials has been 1%. Efforts to overcome these health inequities require a transformative approach to improve patients’ understanding and trust in clinical research. We developed a clinical trial database and geospatial (GEOINT)7 model, validated in COVID-19, to demonstrate enrollments and proximity of clinical trials and community pharmacies to REMGs. Our findings show that 95% of REMGs reside within 3.75 miles of pharmacies and 95% within 87 miles of COVID-19 clinical trials, with observed low enrollments. In this application we apply this model to chronic diseases (asthma, COPD, diabetes, and hypertension) with high prevalence, morbidity, and mortality. Given that pharmacists and community pharmacies are well established in REMG communities, we posit they could serve as resources to increase participation in decentralized clinical trials (DCTs) and to maximize access to precision healthcare. Building on our prior work, our proposed research advances knowledge by leveraging the proximity of pharmacists to REMG communities, taking advantage of whole exome sequencing (WES)), GEOINT, AI, ML, and Clintrials.gov data. Thus, we propose a REMG-community pharmacy-based initiative with data visualization technologies to optimize therapeutics via pharmacogenomics (PGx) and increase clinical trial participation as a healthcare model for REMGs with multiple chronic conditions. |
udeani@tamu.edu |
Research |
3/31/2024 |
|
|
Internal Institutional Partners, External Partners, Chronic Disease, Infectious Disease, Inclusive Study Design, Appropriate Language and Translation Services, Culturally Appropriate Materials, Community-based Research, Inclusive Study Design, Appropriate Language and Translation Services, Culturally Appropriate Materials, Community-based Research, Language, Mistrust, Access (physical/geographical), Access (time), Knowledge, Internal Funding, American Indian or Alaska Native or Alaska Native, Black or African American, Native Hawaiian or Other Pacific Islander, Hispanic or Latino, LGBTQIA+, Young Adults, Middle-Aged, Adults, Older Adults, Medicare Population, Medicaid Population, Rural,Urban, Patients, Pharmacists, Ongoing |
| East Tennessee State University |
Public |
Traditional |
TN |
Dr Robinson and Dr. Gray are acting as facilitators for CPESN-TN and RxE2 initiative to recruit patients for a diabetes clinical trial in the Knoxville area. The goal is to expand patient awareness and referral of eligible patients to IRB clinical trials. Specifically those patients who meet inclusion criteria and have interest in a clinical trial within 30 miles of Knoxville, TN. All patients, regardless of age, sex, or race will be reviewed for eligibility and interest. Inclusive. Eligibility is defined by the clinical trial site. |
GRAYJA02@ETSU.EDU |
Research |
1/22/2024 |
Number of pharmacies involved, patients interviewed and eligible patients referred. |
|
External Partners, Chronic Disease, Access (physical/geographical), Access (time), Mistrust, For-profit Funding, Patients, Ongoing |
| Harding University |
Private |
Accelerated |
AR |
HIV disproportionately affects minorities who participated in less than 1% of all clinical trials that led to the approval of anti-HIV drugs. This service activity/community engagement aimed to increase participation of minorities in HIV clinical trials by providing services focused on improving the clinical pharmacology of anti-HIV drugs and reducing HIV viral loads among the poorest and sickest minorities with HIV. The role of the pharmacy faculty and other collaborators consisted in reaching out to local, national, and international community HIV groups to organize and carry out events designed to raise awareness about the HIV 2030 global health initiatives. |
lkamdem@harding.edu |
Service, Education |
6/16/2017 |
Number of community members contacted; Number of individuals trained/educated |
7/31/2018 |
Internal Institutional Partners, External Partners, Infectious Disease, Inclusive Study Design, Appropriate Language and Translation Services, Culturally Appropriate Materials, Language, Mistrust, Access (physical/geographical), Knowledge, Non-profit funding, Black or African American, Pharmacists, Student Pharmacists, Other Health Professionals, Investigators, Patients, Community Members, Pregnant/Lactating Women, Pediatric, Young Adults, Middle-Aged Adults, Older Adults, Individuals Below Federal Poverty Level, Rural, Completed |
| Auburn University |
Public |
Traditional |
AL |
The goal of RIDE Council is to increase the diversity in research studies on multiple sclerosis. iConquerMS, a patient-centered research community, established RIDE council in 2021. Potential members were recruited and selected by the steering committee. The council members meet virtually for 1-4 hours per month in either a large group or sub-councils that focus on specific underserved communities. Primarily, RIDE has 3 sub-councils, including Black community, Hispanic community, and emerging community (e.g., LGBTQ). The council discussed the historical roots of underrepresentation in research. The council co-designed strategies for increasing meaningful and beneficial research participation. The discussion centers around the increasing research participation in the iConquerMS network, which includes researchers across the country. Later, the council will provide guidance to other research initiatives. The council has promoted RIDE to researchers and encourage them to work with RIDE council to increase the diversity of participants in their research studies, including clinical trials. Specifically, researchers have to first submit their requests to the steering committee members to gauge the council's interest. The researchers are then invited to present or share their project information with the council members. |
szn0053@auburn.edu |
Research, Service |
1/2/2023 |
|
|
External Partners, Rare Disease, Inclusive Study Design, Community-based Research, Culturally Appropriate Materials, Appropriate Language and Translation Services, Knowledge, Mistrust, Access (physical/geographical), Barrier: Access (time), Non-profit funding, Black or African American, Hispanic or Latino, LGBTQIA+, Ongoing |
| Auburn University |
Public |
Traditional |
AL |
The goal of this project was to build a capacity for patient-centered comparative effectiveness research (CER) on multiple sclerosis. The project partners and project lead co-created training materials. We conducted several training workshops, e.g., research methodology (e.g., research design), disease and its treatment, and patient engagement. We brainstormed to generate research questions that are important to patients and their family members. We asked them to prioritize these questions and also developed a mind map to summarize the research topics. Finally, we created a patient-led research community, which includes not only patients and their family members living in AL and MS, but also healthcare providers and researchers. |
szn0053@auburn.edu |
Service, Education |
1/1/2021 |
PCORI Engagement Awards Evaluation Reporting Tool (based on Reach, Engagement,Adoption, and Implementation) |
12/31/2022 |
Internal Institutional Partners, External Partners, Rare Disease, Inclusive Study Design, Community-based Research, Knowledge, Non-profit funding, Black or African American, Community Members, Investigators, Other Health Professionals, Completed |
| Auburn University |
Public |
Traditional |
AL |
The goal of this project is to build a capacity for patient-centered comparative effectiveness research (CER) on maternal health in Black women. First, we established a consortium of black woman who has pregnancy experience, healthcare provider, and a church pastor. We conducted several training workshops, e.g., research methodology (e.g., research design), maternal health, and patient engagement, using PCORI resources. We generated research questions that are important to patients and their family members. Finally, we created a patient-led research community. |
szn0053@auburn.edu |
Service, Education |
1/2/2023 |
PCORI Engagement Awards Evaluation Reporting Tool (based on Reach, Engagement,Adoption, and Implementation) |
|
Internal Institutional Partners, External Partners, Pregnancy/Lactation, Inclusive Study Design, Community-based Research, Mistrust, Knowledge, Non-profit funding, Black or African American, Community Members, Ongoing |
| Auburn University |
Public |
Traditional |
AL |
The goal of this project is to build a capacity for patient-centered comparative effectiveness research (CER) on healthcare system delivery for Korean people. We conducted several training workshops, e.g., research methodology (e.g., research design), healthcare system, and patient engagement. We generated research questions that are important to patients and their family members. Finally, we created a patient-led research community. |
szn0053@auburn.edu |
Service, Education |
3/1/2024 |
PCORI Engagement Awards Evaluation Reporting Tool (based on Reach, Engagement,Adoption, and Implementation) |
|
Inclusive Study Design, Language, Mistrust, Access (physical/geographical), Access (time), Knowledge, Student Pharmacists, Completed |
| Medical College of Wisconsin |
Private |
Accelerated |
WI |
The title of this program was Developing a Framework of Diversity, Equity, and Inclusion in Pharmacy Research. MCW partnered with Froedtert Hospital Pharmacy Department to bring together a panel of speakers to provide 1 hour lectures of efforts the pharmacy department or pharmacists in general could take a look at research from a DEI lens. The purpose was to prompt pharmacist primary investigators on our campus to incorporate DEI in study design and using inclusive language throughout all project proposals. |
kbusse@mcw.edu |
Education |
2/15/2023 |
|
4/30/2023 |
External Partner, Inclusive Study Design, Culturally Appropriate Materials, Language, Knowledge, Mistrust, Non-profit funding, Pharmacists, Investigators, Completed |
| Virginia Commonwealth University |
Public |
Traditional |
VA |
The Richmond Health and Wellness Program (RHWP) was created in 2012 as an inter-professional model of care to address the unmet needs of low-income older adults with multiple chronic conditions. Faculty from the VCU Schools of Pharmacy, Nursing, Social Work, and Medicine created the program with a community engaged research pilot grant from the university. The program has been providing weekly free wellness services to low-income older adults living in high-rise housing units for over a decade. The resident participants are on average age of 73 years old, 82% of individuals are African American with an average of 3.5 chronic conditions. RHWP currently provides wellness based clinical services for community dwelling seniors within approximately 1500 subsidized housing units. The weekly clinics provide wellness checks, medication management, behavioral health services, occupational therapy, physical therapy and healthy meals. The resident participants that are served by RHWP have representatives from each housing community on the RHWP Resident Council. The RHWP Resident Council provides direction for the program and informs the faculty of desired programs for RHWP. The Resident Council also participates in the development and implementation of research within RHWP. The weekly wellness clinics improve the health and well beings of the participants. Additionally, RHWP clinical faculty become trusted allies within the respective communities. This trust has contributed to the development of multiple research collaboratives within the weekly clinical programs. Currently, we have externally funded clinical studies or trials in pharmacogenomics, digital health/technology, and nutrition underway. In 2023, We successfully consented 617 unique RHWP participants and conducted 3092 total visits. |
etprice@vcu.edu |
Research, Service, Education |
1/2/2012 |
Unique participants; Total visits. |
|
External Partners, Internal Institutional Partners, Inclusive Study Design, Appropriate Language and Translation Services, Community-based Research, Access (time), Access (physical/geographical), Mistrust, Funding, Internal Funding, Federal External Government Funding: NIH, Clinical and Translational Science Awards, Non-profit funding, Black or African American, White, Pharmacists, Student Pharmacists, Other Health Professionals , Investigators, Community Members, Older Adults, Medicare Population, Individuals Below Federal Poverty Level, Rural, Urban, Health Professional Shortage Area, Ongoing |
| Texas A&M University |
Public |
Traditional |
TX |
Use the SA! Communication Infrastructure, Virtual Platforms, and Traditional Channels -- In collaboration with our community partners and stakeholders and working synergistically with our CTSA, we will enhance diversity, inclusion, and access by using multiple channels, including the Salud America! (i.e., online posts, action packs, podcasts, infographics, factsheets, social media), and virtual telehealth platforms such as ECHO® to engage new and existing community partners and stakeholders to raise awareness of CTSA projects focused on community engagement science, health equity, and other research activities. |
udeani@tamu.edu |
Research, Service |
|
|
|
Internal Institutional Partners, External Partners, Infectious Disease, Clinical and Translational Science Awards, Internal Funding, Inclusive Study Design, Culturally Appropriate Materials, Appropriate Language and Translation Services, Hispanic or Latino, Black or African American, Community Members, Young Adults, Other Health Professionals |
| University of New Mexico |
Public |
Traditional |
NM |
The University of New Mexico College of Pharmacy has an active partnership with the Clinical and Transnational Sciences Center (CTSC). The Integrative Special Populations (ISP) Committee is working to enhance opportunities for underserved and special populations across the lifespan to participate in and benefit from clinical and translational research. The ISP team helps researchers consider various research methods and unique therapies, practices, or interventions that may be needed to reach these populations. Other activities include outreach to clinicians and community stakeholders, clinical research education for non-experts and underserved communities, and training for investigators on creating more inclusive protocols and recruitment strategies. It helps to identify and connect investigators to potential engagement partners, collaborators, and UNM CTSC resources and services. It is based on best practices and specific considerations for New Mexico’s special populations.The program has been ongoing for 5+ years and has been a part of the CTSC application. For more information see: https://hsc.unm.edu/ctsc/services/cerc/special-populations.html |
lbakhireva@salud.unm.edu |
Research, Education |
|
|
|
Internal Institutional Partners, External Partners, Inclusive Study Design, Community-based Research, Clinical and Translational Science Awards, Investigators, Community Members |
| University of New Mexico |
Public |
Traditional |
NM |
University of New Mexico Center for Native American Health has been operating for 5+ years and focuses on the following activities: (1) Mentorship (or co-mentorship) for students including UNM’s Required Medical Student Research, graduate thesis and dissertation research, and Independent Study sponsorship; (2) Partnership building with tribal and off-Reservation American Indian or Alaska Native communities for research with a focus on cultural humility and Indigenous knowledge; (3) Developing culturally-appropriate and engaging research methods such as focus group design/facilitation, (4) Community Advisory Panel development, and meeting facilitation; (5) Organizing and securing institutional and tribal human research protections approval; (6) Building capacity for community-based participatory research (CBPR) by co-teaching an annual CBPR Institute at the UNM HSC; and (7) One-on-one consultation.The IPS RESPONSE team consists of experienced faculty and staff with mixed-methods expertise that provide pre-proposal consultations for local investigators and cross-hub collaborators. Consultations will focus on best practices and considerations in New Mexico’s special populations, and identify and connect investigators to potential engagement partners, collaborators, and UNM CTSC resources and services. The team coordinates closely with other CTSC cores such asthe Community Engagement and Research Core (https://hsc.unm.edu/ctsc/services/cerc/) and Participant and Clinical Interactions (https://hsc.unm.edu/ctsc/services/participant-clinical-interactions/). Consults currently are occurring via web-based technology. |
lbakhireva@salud.unm.edu |
Research, Education, Service |
|
|
|
Internal Institutional Partners, External Partners, Community-based Research, Culturally Appropriate Materials, Inclusive Study Design, Mistrust, American Indian or Alaska Native, Investigators, Community Members, Other Health Professionals |
| Xavier of Louisiana University |
Private |
Traditional |
LA |
Researchers at Xavier University of Louisiana use a Community Advisory Board (CAB) meeting as a resource when planning to conduct clinical trials. The academic researcher presents the proposal to the CAB members asking for feedback on the study design, especially regarding recommendations that would make the proposed research more relevant to the community and encouraging to community members for enrollment. The CAB receives technical assistance from the Louisiana Clinical & Translational Science Center (LACaTS Center), a state-wide collaboration between multiple academic, research and health care delivery institutions organized around a central theme of “Addressing health disparities and improving health outcomes in our underserved population with chronic diseases.” |
kkenned1@xula.edu |
Research |
|
|
|
External Partners, Inclusive Study Design, Community-based Research, External Government Funding, Investigators |
| Xavier of Louisiana University |
Private |
Traditional |
LA |
Xavier University of Louisiana and Tulane Medical school are participating in the Louisiana Community Engagement Alliance (LA CEAL), part of the nation-side CEAL network funded by NIH to engage communities to reduce COVID-19 health disparities and COVID spread. Phase I of the LA CEAL study began to decrease COVID-19 vaccine hesitancy. The purpose of Phase II is to increase enrollment in clinical trials, primarily through partnerships with faith-based and non-profit community organizations. Researchers are conducting focus groups to engage and educate the community, first on the importance of vaccines and then on clinical trial participation. |
llgeorge@xula.edu |
Research |
|
|
|
External Partners, Infectious Disease, Federal External Government Funding: NIH, Community Members |
| Xavier of Louisiana University |
Private |
Traditional |
LA |
Description: A clinical pharmacy faculty member at Xavier University of Louisiana participates in TMIST (Tomosynthesis Mammographic Imaging Screening Trial), a clinical trial funded by NCI to determine the best way to diagnose breast cancer with different types of mammograms. The clinical pharmacy faculty member provides education to the community at health fairs to encourage enrollment, particularly of African American women. The trial is funded by NCI and TICADA. |
jeugene@xula.edu |
Research, Education |
|
|
|
External Partners, Cancer, Federal External Government Funding: NIH, Black or African American, Community Members , Knowledge, Barriers: Access (time), Access (physical/geographical) |
| Florida A&M University |
Public |
Traditional |
FL |
Through a grant funded by the U.S. Food and Drug Administration (FDA), faculty at the Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences and Institute of Public Health will identify the major barriers in local communities contributing to the low enrollment of racial and ethnic minority populations in COVID-19 clinical trials. Researchers will analyze data provided by the Florida Community Engagement Alliance (CEAL) and other sources to determine primary data gaps regarding participation in COVID-19 trials in Florida. This activity is ongoing as part of the FDA grant. |
Jocelyn.spates@famu.edu |
Research |
|
|
|
Internal Institutional Partners, Infectious Disease, Federal External Government Funding: FDA |
| Florida A&M University |
Public |
Traditional |
FL |
Through a grant funded by the U.S. Food and Drug Administration (FDA), faculty at the Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences will develop, pilot, and evaluate a community-based targeted strategy to actively improve the enrollment of the racial and ethnic minority population in local COVID-19 clinical trials. In November/December 2022 and January 2023, researchers will conduct qualitative group interviews with the community to discuss strategies and education methods to increase enrollment for minority populations in clinical trials. The interviews will be conducted in multiple types of organizations, institutions, and/or establishments in racial and ethnic minority communities, including, but not limited to churches, beauty salons/barber shops, colleges, vocational and trade schools, health fairs, and COVID-19 testing sites. Researchers will also conduct interviews with community healthcare providers, leaders, etc., to discuss strategies/training/education methods to increase racial and ethnic minority enrollment in local COVID-19 clinical trials. Participants will include the following types of community workers including, but not limited to: Pharmacists, Physicians, Nurses, Student Pharmacists (FAMU), Social Workers, Psychologists, Community Health Workers, Community leaders, Faith-Based leaders, Healthcare Workers from FQHCs. |
Jocelyn.spates@famu.edu |
Research, Education |
|
|
|
External Partners, Infectious Disease, Inclusive Study Design, Federal External Government Funding: FDA, Health Professionals, Pharmacists, Student Pharmacists, Community Members |
| Florida A&M University |
Public |
Traditional |
FL |
Through a grant funded by the U.S. Food and Drug Administration (FDA), faculty at the Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences will develop pilot and evaluate a community-based targeted strategy to actively improve the enrollment of the racial and ethnic minority population in local COVID-19 clinical trials. In Spring 2023, investigators will identify community health advisors/ambassadors in target geographic areas to participate in educational sessions with the investigators. The investigators include pharmacists, pharmaceutical scientists, student pharmacists, and other health professionals who will engage in education and training of health advisors/ambassadors on topics including but not limited to the biology of SARS-COV2, COVID-19 infection, COVID-19 vaccines, the benefits and risks of participating in COVID-19 clinical trials, the role of the pharmaceutical industry in conducting clinical trials, barriers to enrollment, and medical research mistrust. The investigators will develop training materials to be used by the community health advisors/ambassadors. These community health advisors/ambassadors will use the aforementioned training to facilitate four educational sessions for racial and ethnic minority groups within their communities. The participants will receive a pre and post assessment to gauge their knowledge and willingness in clinical trial enrollment. The participants will also receive a speaker and learning objective evaluation. |
Jocelyn.spates@famu.edu |
Research, Education |
|
|
|
External Partners, Infectious Disease, Culturally Appropriate Materials, Federal External Government Funding: FDA, Health Professionals, Pharmacists, Student Pharmacists, Other Health Professionals, Community Members, Investigators |
| Florida A&M University |
Public |
Traditional |
FL |
Through a grant funded by the U.S. Food and Drug Administration (FDA), faculty at the Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences will develop, pilot, and evaluate a community-based targeted strategy to actively improve the enrollment of the racial and ethnic minority population in local COVID-19 clinical trials. In Spring 2023, faculty will develop a website for the public that will contain information and resources about clinical trials. The website will focus on topics including but not limited to the biology of SARS-COV2, COVID-19 infection, COVID-19 vaccines, the benefits and risks of participating in COVID-19 clinical trials, the role of the pharmaceutical industry in conducting clinical trials, barriers to enrollment, and medical research mistrust. The website will also include testimonials of clinical trial participants and information on frequently asked questions regarding vaccines. |
Jocelyn.spates@famu.edu |
Research, Service |
|
|
|
Inclusive Study Design, Language, Mistrust, Access (physical/geographical), Access (time), Knowledge, Student Pharmacists, Completed |
| Florida A&M University |
Public |
Traditional |
FL |
Provide Clinical Research training for 30 minority healthcare providers and workers in three geographic areas (Jacksonville, Tampa, Tallahassee, FL) and three research investigators in Spring 2023. |
Jocelyn.spates@famu.edu |
Education |
|
|
|
Other Health Professionals, Investigators |
| University of Texas at Austin |
Public |
Traditional |
TX |
A novel, live, online program was developed and offered for faculty and clinical research professionals (CRPs) to increase the number of trained clinical trial personnel. This is called the Clinical Trial Scholars Program (CTSP). Program goals are to provide career development opportunities and increase the success rate in capitalizing on industry-sponsored clinical trial opportunities. The activities began in September 2022 and ran until April 4th, 2023 with a total of 8 sessions. The program secured 7-year funding, totaling 22 years after this, and emerged as a university-wide effort stemming from CTSA endeavors, welcoming faculty and CRPs. With a hybrid option available, efforts were made to broaden participation beyond medicine, extending to various professions and roles. The involvement of pharmacists was considered, with discussions on participants, speakers, and the incorporation of ethics and regulatory issues. Excitement and interest surged, necessitating enrollment cutoff at 155, with 30-40 attendees per session, offering the choice of specific sessions or completing the entire program for an electronic badge. Pharmacy interest, mainly among clinical faculty at assistant and associate levels, was noted. Diversity elements were addressed through sessions like the panel on participant recruitment/retention, focusing on Latinx populations. Metrics and outcomes related to activities were rolled out swiftly, incorporating questions at the end of each session and key assessments aimed at fostering connections, knowledge acquisition, and community building. Barriers to increasing diversity in clinical trials were explored in a panel session featuring three speakers, including Amelie Ramirez from the Institute for Health Promotion, who discussed leveraging grants, social media, community health workers (CHWs), and training to engage Latinx populations effectively . The activity is part of our NIH/NCATS/CTSA proposal. |
freic@uthscsa.edu |
Education |
4/4/2023 |
|
|
Internal Institutional Partners, External Partners, Clinical and Translational Science Awards, Internal Funding, Hispanic or Latino, Investigators, Pharmacist, Health Care Professionals, Barrier Addressed: Mistrust, Access (time), Access (physical/geographical), Ongoing |
| University of Texas at Austin |
Public |
Traditional |
TX |
UT Austin’s Dell School of Medicine expanded their existing program to include NIH/NCATS/CTSA Partners in the “Nuts and Bolts” program. The goal is to provide clinical trial personnel with informational support and a community of learners to navigate conducting investigator-initiated clinical trials and population-based studies. This will be a synchronous, monthly, online, 1-hour forum, from August to June of each year. Selected topics include developing protocols and procedures, SOPs, IRB applications, working parts of a clinical trial, recruitment, and retention (including underrepresented populations), data collection and data quality management, and research integrity. The activity is part of a NIH/NCATS/CTSA proposal. The activities began in September 2023. |
freic@uthscsa.edu |
Education |
9/1/2023 |
|
|
Internal Institutional Partners, External Partners, Clinical and Translational Science Awards, Internal Funding, Hispanic or Latino, Investigators, Pharmacist, Other Health Professionals |
| University of Texas at Austin |
Public |
Traditional |
TX |
Investigators will collaborate with community partners and stakeholders within our CTSA to enhance diversity, inclusion, and access by using multiple channels, including the Salud America! (i.e., online posts, action packs, podcasts, infographics, factsheets, social media) and virtual telehealth platforms such as ECHO®. Through these mechanisms, new and existing community partners and stakeholders will be engaged to raise awareness of CTSA projects focused on community engagement science, health equity, and other research activities. The activity is part of our NIH/NCATS/CTSA proposal. The activities will begin in September 2023. |
freic@uthscsa.edu |
Service |
9/1/2023 |
|
|
Internal Institutional Partners, External Partners, Community-based Research, Clinical and Translational Science Awards, Internal Funding, Hispanic or Latino, Community Members, Culturally Appropriate Materials |
